Abstract:Objective:To provide experimental evidence for panel determination in clinical practice, we characterized the early changes of surfactant proteins B (SP-B), plasminogen activator inhibitor-1 (PAI-1), high-mobility group box B1 (HMGB1) and soluble receptor for advanced glycation end products (sRAGE) in acute respiratory distress syndrome (ARDS) induced by lipopolysaccharide (LPS).Methods:In the Institute of Cardiopulmonary Cerebral Resuscitation, Sun Yat Sen University, 36 SD rats were randomly (random number) divided into the LPS group and control group. ARDS rat model in the LPS group was established by intrapulmonary injection of LPS (10 μg/mL) synchronously intrapulmonary injection of saline in the control group. Serum, bronchoalveolar lavage fluid (BALF) and lung tissues were collected at 6, 12 and 24 h after ( n=6 at each time point). After confirmed the success of ARDS model by arterial blood gas (PaO 2) and pathology, we determinated the expressions of SP-B, PAI-1, HMGB1 and sRAGE by enzyme linked immunoassay, immunohistochemistry and Western blot. Paired t test and repeated measurement ANOVA were used for comparison of these biomarkers between the two groups. Results:Progressively decreases of PaO 2 (80.38±1.74 vs 84.17±1.96; 72.20±1.70 vs 81.26±1.57; 68.52±2.45 vs 81.45±1.51) and synchronously worse deterioration at HE pathology were found in the LPS group than those in the control group ( P<0.05). Compared to the control group, a progressively significant increases in HMGB1 (ng/mL) (0.34±0.08, 0.43±0.12, 0.50±0.03), PAI-1 (ng/mL) (40.38±3.06, 50.02±4.82, 57.34±4.67) and SP-B (ng/mL) (2.21±0.11, 2.74±0.15, 3.07±0.28) but significant decreases at sRAGE (ng/mL) (0.17±0.04, 0.14±0.04, 0.11±0.02) were revealed in the serum of LPS group ( P<0.05). Another similarly significant increases in HMGB1 (ng/mL) (0.08±0.02, 0.13±0.02, 0.21±0.03), PAI-1 (ng/mL) (48.88±4.17, 56.66±4.01, 65.83±4.96) and SP-B (ng/mL) (0.68±0.13, 0.80±0.17, 1.12±0.14), but significant decreases at sRAGE (ng/mL) (0.14±0.05, 0.12±0.02, 0.11±0.02) in the BALF of the LPS group compared with those in control group ( P<0.05). Immunohistochemistry showed a consistent up-regulating started at 6 h appeared at PAI-1 (from lung interstitium to lung parenchyma), HMGB1 and SP-B (from lung parenchyma to lung interstitium) while a down-regulating at sRAGE in the LPS group. Western blot showed the elevated expression of SP-B, PAI-1 and HMGB1 but the descent expression of sRAGE following the treating time in the LPS group. Conclusions:In the early stage of ARDS, SP-B, PAI-1 and HMGB1 synchronously changes in serum, and BLAF and lung tissue had the similar tendency, of which can help clinician to early diagnose and identify ARDS by choosing one or combining the biomarkers.

Clinical Significance of 8-Lsoprostaglandin in Exhaled Breath Condensate of Patients with Acute Lung Injury

Variations and Significance of IL-8 in the Bronchoalveolar Lavage Fluid in the Perioperative Period of Cardiopulmonary Bypass Operation on Children

Clinic significances of 8-isoprostane in Exhaled Breath Condensate in COPD

Serum Levels of IGFBP7 Are Elevated During Acute Exacerbation in COPD Patients.

The Clinical Study on Seventy Four Patients with Acute Pulmonary Contusion

Change and significance of 8-isoprostane in exhaled breath condensate in obstructive sleep apnea-hypopnea syndrome

The relationship between the level of NO,8-isoprostane in exhaled breath condensate and the serious condition of patients with asthma

Determination of Biomarkers in Exhaled Breath Condensation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Clinical Implications

Clinical significance of nitric oxide and 8-isoprostane in exhaled breath condensate in chronic obstructive pulmonary disease

The Relationship Between Soluble Cd74, Scd14 And Severity And Prognosis In Patients With Acute Respiratory Distress Syndrome

Determination of Serum Pulmonary Surfactant Protein A and Its Significance in Patients with Acute Lung Injury

Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease

Changes in the Concentrations of Mediators of Inflammation and Oxidative Stress in Exhaled Breath Condensate During Liver Transplantation and Their Relations With Postoperative ARDS

Prognostic value of the extravascular lung water and pulmonary vascular permeability indices in severe adult respiratory distress syndrome managed with extracorporeal membrane oxygenation

The Changes of Four Cell-Resource Biomarkers in Rats with Acute Respiratory Distress Syndrome

The clinical significance of plasma surfactant protein-D in patients with septic ARDS

[Prognostic Value of Assay of Brain Natriuretic Peptide in Patients with Acute Respiratory Distress Syndrome].

Serum 8-iso-PGF2α Predicts the Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Retrospective Cohort Study

The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness

The Characteristics and Clinical Significance of Mucin Levels in Bronchoalveolar Lavage Fluid of Patients with Interstitial Lung Disease.

Plasma long noncoding RNA IL-7R as a prognostic biomarker for clinical outcomes in patients with acute respiratory distress syndrome.